Raymond James Trust’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-13,713
Closed -$346K 1079
2022
Q2
$346K Buy
13,713
+1,500
+12% +$44.9K 0.01% 738
2022
Q1
$441K Buy
12,213
+513
+4% +$25.3K 0.01% 687
2021
Q4
$897K Sell
11,700
-299
-2% -$26.4K 0.03% 456
2021
Q3
$1.15M Buy
11,999
+44
+0.4% +$4.8K 0.04% 367
2021
Q2
$1.27M Buy
11,955
+462
+4% +$45.5K 0.04% 333
2021
Q1
$1.03M Sell
11,493
-3,813
-25% -$420K 0.04% 364
2020
Q4
$1.54M Buy
15,306
+475
+3% +$35.4K 0.06% 266
2020
Q3
$725K Buy
14,831
+454
+3% +$21.8K 0.03% 387
2020
Q2
$587K Sell
14,377
-1,708
-11% -$49.1K 0.03% 419
2020
Q1
$247K Buy
+16,085
New +$338K 0.01% 626

Other funds holding CRNC

Raymond James Trust's CRNC Position: Q3 2022 in Review

Raymond James Trust sold out of Cerence (CRNC) in Q3 2022, closing a stake of 13,713 shares — an estimated $346K sold.

Raymond James Trust first reported a position in CRNC in Q1 2020 and held it in 10 quarters. The position peaked at $1.54M in Q4 2020. 230 funds tracked by Wall St. Rank hold CRNC as of Q3 2022.

  • Raymond James Trust reported no remaining Cerence position as of Q3 2022 after selling out during the quarter.
  • Raymond James Trust sold 13,713 Cerence shares in Q3 2022, an estimated $346K.
  • Raymond James Trust first reported a position in Cerence in Q1 2020 and held it in 10 quarters.
  • Raymond James Trust's Cerence position peaked at $1.54M in Q4 2020.
  • 230 funds tracked by Wall St. Rank held Cerence as of Q3 2022.

Based on Raymond James Trust's 13F filing for Q3 2022, filed 31 Oct 2022.